Search

everythinglearnresearchcommunity

for

Search:↓

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Most patients improved with oral contraceptives, but some needed additional treatment.